180 related articles for article (PubMed ID: 9283794)
1. Role of IGF binding protein-1 in the dawn phenomenon and glycemic control in children and adolescents with IDDM.
Kobayashi K; Amemiya S; Sawanobori E; Higashida K; Ishihara T; Kobayashi K; Kato K; Nakazawa S
Diabetes Care; 1997 Sep; 20(9):1442-7. PubMed ID: 9283794
[TBL] [Abstract][Full Text] [Related]
2. The 'dawn phenomenon' in adolescents with insulin dependent diabetes mellitus: possible contribution of insulin-like growth factor binding protein-1.
Cotterill AM; Daly F; Holly JM; Hughes SC; Camacho-Hübner C; Abdulla AF; Gale EA; Savage MO
Clin Endocrinol (Oxf); 1995 Nov; 43(5):567-74. PubMed ID: 8548941
[TBL] [Abstract][Full Text] [Related]
3. Nocturnal blood glucose and IGFBP-1 changes in type 1 diabetes: Differences in the dawn phenomenon between insulin regimens.
Yagasaki H; Kobayashi K; Saitou T; Nagamine K; Mitsui Y; Mochizuki M; Kobayashi K; Cho H; Ohyama K; Amemiya S; Nakazawa S
Exp Clin Endocrinol Diabetes; 2010 Mar; 118(3):195-9. PubMed ID: 19834874
[TBL] [Abstract][Full Text] [Related]
4. Is growth hormone hypersecretion in diabetic adolescent girls also a daytime problem?
Halldin MU; Tylleskär K; Hagenäs L; Tuvemo T; Gustafsson J
Clin Endocrinol (Oxf); 1998 Jun; 48(6):785-94. PubMed ID: 9713569
[TBL] [Abstract][Full Text] [Related]
5. Effect of glycemic control on growth hormone and IGFBP-1 secretion in patients with type I diabetes mellitus.
Salgado LR; Semer M; Nery M; Knoepfelmacher M; Lerário AC; Póvoa G; Jana S; Villares SM; Wajchenberg BL; Liberman B; Nicolau W
J Endocrinol Invest; 1996; 19(7):433-40. PubMed ID: 8884537
[TBL] [Abstract][Full Text] [Related]
6. The involvement of growth hormone-binding protein in altered GH-IGF axis in IDDM.
Kobayashi K; Amemiya S; Kobayashi K; Sawanobori E; Mochizuki M; Ishihara T; Higashida K; Miura M; Nakazawa S
Endocr J; 1999 Mar; 46 Suppl():S67-9. PubMed ID: 12054124
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor I, its binding proteins 1 and 3, and growth hormone-binding protein in children and adolescents with insulin-dependent diabetes mellitus: clinical implications.
Muñoz MT; Barrios V; Pozo J; Argente J
Pediatr Res; 1996 Jun; 39(6):992-8. PubMed ID: 8725260
[TBL] [Abstract][Full Text] [Related]
8. The effects of pubertal status and glycemic control on the growth hormone-IGF-I axis in boys with insulin-dependent diabetes mellitus.
Clark PA; Clarke WL; Pedadda S; Reiss A; Langlois C; Nieves-Rivera F; Rogol AD
J Pediatr Endocrinol Metab; 1998; 11(3):427-35. PubMed ID: 11517959
[TBL] [Abstract][Full Text] [Related]
9. A role of free insulin-like growth factor-I in dawn phenomenon in children and adolescents with type 1 diabetes mellitus.
Kobayashi K; Kobayashi K; Mochizuki M; Matsushita K; Sawanobori E; Ishihara T; Higashida K; Amemiya S
Endocr J; 2000 Mar; 47 Suppl():S91-3. PubMed ID: 10890193
[TBL] [Abstract][Full Text] [Related]
10. Insulin-like growth factors and binding proteins in patients with recent-onset type 1 (insulin-dependent) diabetes mellitus: influence of diabetes control and intraportal insulin infusion.
Shishko PI; Dreval AV; Abugova IA; Zajarny IU; Goncharov VC
Diabetes Res Clin Pract; 1994 Aug; 25(1):1-12. PubMed ID: 7530621
[TBL] [Abstract][Full Text] [Related]
11. Free and total insulin-like growth factor I (IGF-I), IGF-binding protein-1 (IGFBP-1), and IGFBP-3 and their relationships to the presence of diabetic retinopathy and glomerular hyperfiltration in insulin-dependent diabetes mellitus.
Janssen JA; Jacobs ML; Derkx FH; Weber RF; van der Lely AJ; Lamberts SW
J Clin Endocrinol Metab; 1997 Sep; 82(9):2809-15. PubMed ID: 9284701
[TBL] [Abstract][Full Text] [Related]
12. Use of the ligand immunofunctional assay for human insulin-like growth factor ((IGF) binding protein-3 (IGFBP-3) to analyze IGFBP-3 proteolysis and igf-i bioavailability in healthy adults, GH-deficient and acromegalic patients, and diabetics.
Lassarre C; Duron F; Binoux M
J Clin Endocrinol Metab; 2001 May; 86(5):1942-52. PubMed ID: 11344189
[TBL] [Abstract][Full Text] [Related]
13. Serum insulin-like growth factor II levels in normal adolescents and those with insulin dependent diabetes mellitus.
Acerini CL; Clayton KL; Hintz R; Baker B; Watts A; Holly JM; Dunger DB
Clin Endocrinol (Oxf); 1996 Jul; 45(1):13-9. PubMed ID: 8796133
[TBL] [Abstract][Full Text] [Related]
14. Abnormal regulation of insulin-like growth factor binding proteins in adolescents with insulin-dependent diabetes.
Batch JA; Baxter RC; Werther G
J Clin Endocrinol Metab; 1991 Nov; 73(5):964-8. PubMed ID: 1719017
[TBL] [Abstract][Full Text] [Related]
15. Changes in free insulin-like growth factor-1 and leptin concentrations during acute metabolic decompensation in insulin withdrawn patients with type 1 diabetes.
Attia N; Caprio S; Jones TW; Heptulla R; Holcombe J; Silver D; Sherwin RS; Tamborlane WV
J Clin Endocrinol Metab; 1999 Jul; 84(7):2324-8. PubMed ID: 10404797
[TBL] [Abstract][Full Text] [Related]
16. Insulin-like growth factors and their binding proteins in children with IDDM.
Wacharasindhu S; Srivuthana S; Aroonparkmongkol S
J Med Assoc Thai; 2002 Jan; 85(1):41-52. PubMed ID: 12075719
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the components of insulin-like growth factor (IGF)-IGF binding protein (IGFBP) system in adolescents with type 1 diabetes and persistent microalbuminuria: relationship with increased urinary excretion of IGFBP-3 18 kD N-terminal fragment.
Spagnoli A; Chiarelli F; Vorwerk P; Boscherini B; Rosenfeld RG
Clin Endocrinol (Oxf); 1999 Nov; 51(5):587-96. PubMed ID: 10594519
[TBL] [Abstract][Full Text] [Related]
18. Relationship between serum leptin and the insulin-like growth factor-I system in humans.
Grégoire Nyomba BL; Johnson M; Berard L; Murphy LJ
Metabolism; 1999 Jul; 48(7):840-4. PubMed ID: 10421222
[TBL] [Abstract][Full Text] [Related]
19. Insulin treatment normalizes reduced free insulin-like growth factor-I concentrations in diabetic children.
Bereket A; Lang CH; Blethen SL; Ng LC; Wilson TA
Clin Endocrinol (Oxf); 1996 Sep; 45(3):321-6. PubMed ID: 8949570
[TBL] [Abstract][Full Text] [Related]
20. Altered relation between circulating levels of insulin-like growth factor-binding protein-1 and insulin in growth hormone-deficient patients and insulin-dependent diabetic patients compared to that in healthy subjects.
Hilding A; Brismar K; Degerblad M; Thorén M; Hall K
J Clin Endocrinol Metab; 1995 Sep; 80(9):2646-52. PubMed ID: 7545695
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
